Medical Bed Market (By Type: Electric Bed, Semi Electric Bed, Manual Bed; By Application: Outpatient Clinics, Medical Nursing Homes, Medical Laboratory and Research; By Usage: Acute Care, Long Term Care, Psychiatric Care, Maternity) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global medical bed market size was estimated at USD 3.38 billion in 2022 and is projected to hit around USD 6.03 billion by 2032, growing at a CAGR of 6% during the forecast period from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
Medical beds, which range from manually controlled to fully electric, guarantee the patients' comfort while also having cutting-edge features. Additionally, it is projected that the market would rise as a result of healthcare providers' increasing expenditures on hospital infrastructure and patients' access to affordable treatment worldwide. The market is anticipated to increase as a result of factors like the expanding geriatric population and the prevalence of chronic illnesses worldwide. Over the projected period, the market for medical beds is expected to expand at a CAGR of almost 5.8%.
Furthermore, throughout the course of the forecast period, the market is anticipated to rise as a result of technical advancements, the adoption of medical beds, and an increase in the number of hospitals. However, it is projected that the market expansion would be hampered by the high cost of medical beds and a decline in the number of beds in public hospitals.
Medical beds are the equipment used in hospitals for patients who are bedridden or in need of care. Medical beds make it easier to transfer patients, improve patient placement, and reduce the chance that they may roll out of bed.
Patient beds known as manual medical beds are those that can be adjusted manually for the comfort of the patient. Manual medical beds are predicted to support the segment's growth throughout the forecast period because they are less likely to have a motor failure, are less expensive, and have simple operating mechanisms. Due to rising expenditures on hospital infrastructure and an increase in the number of organized hospitals throughout the world, the electric bed market is predicted to develop at a substantial rate.
According to the World Population Ageing Report, the proportion of elder people worldwide, which was about 89.3% in 2020, may rise to 16% by 2050. Furthermore, it is predicted that the market would increase during the forecast period due to the rising elderly population and lifestyle illnesses that require medical beds for better treatment and comfort.
According to the end user, the homecare sector is expected to see rapid market expansion due to the use of medical beds in homecare settings and the rising number of diabetes patients worldwide.
Report Coverage | Details |
Market Size in 2023 | USD 3.57 Billion |
Market Size by 2032 | USD 6.03 Billion |
Growth Rate from 2023 to 2032 | CAGR of 6% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered |
|
Regions Covered |
|
Key Market Drivers
Key Market Challenges
Key Market Opportunities
Semi-electric, electric, and manual medical beds are the three main types available on the market today. According to estimates, the electric bed market would see the greatest CAGR between 2023 and 2032. Electric beds are rapidly expanding in popularity. Additionally, these beds provide a remote-controlled therapeutic massage option for patients who are confined to their beds. This function promotes blood flow and guards against bedsores and joint discomfort. The functionality is activated by default in the mattress. Additionally, neither the patients nor the caretakers need to worry about losing support in the middle of the night or make frequent modifications. The M9 set of beds from Taranaki-based medical bed manufacturer Howard Wright was bought by Hwera Hospital in August 2022.
These beds allowed medical workers to provide patients with greater comfort without having to elevate them. The complete electric controls on the M9 beds allow for full height and position adjustment. Other electric hospital beds on the market include the Zenith9100, the Invacare Full-Electric Homecare Bed, and the DELTA 4 series.
These beds allowed medical workers to provide patients with greater comfort without having to elevate them. The complete electric controls on the M9 beds allow for full height and position adjustment. Other electric hospital beds on the market include the Zenith9100, the Invacare Full-Electric Homecare Bed, and the DELTA 4 series. The Global Cancer Observatory estimates that 19.3 million new cancer cases will be diagnosed globally in 2020, indicating an increase in the incidence of the disease worldwide. Due to its ability to improve nurse workflow efficiency and shorten total in-patient stays, smart hospital beds are predicted to continue to be in high demand.
From 2023 to 2032, the outpatient clinics market is anticipated to grow at a revenue-based CAGR of 7.3%. The expansions of primary healthcare institutions and, as a result, their predominance in rural areas throughout Asia, Africa, and South America have been directly related to improvements in healthcare standards in these nations. The primary diagnostic and first point of care for patients worldwide is provided via outpatient clinics. In addition, the incidence of acute illnesses like the flu, fevers, and bronchitis has been a major role in encouraging people all over the world to visit outpatient clinics. The World Health Organization (WHO) reports that the number of outpatient interactions per person in Europe ranged from 1.9 to 13.1 in 2011 before peaking at 2.6 to 13.5 in 2018.
Over the course of the projection, North America is anticipated to hold a sizable portion of the market. The existence of major market participants, the rising incidence of diabetes, and the well-established healthcare infrastructure are all factors in the market expansion. In addition, it is projected that the region's rising incidence of cancer and other chronic illnesses would spur market expansion. In the United States, there were 1,762,450 new cases of cancer in 2019, according to the National Institute for Health. Because of the region's growing number of hospitals and rising healthcare infrastructure, the Asia-Pacific is expected to experience significant market expansion. Additionally, it is projected that rising hospitalization rates and the burden of sickness in developing nations would promote market expansion.
The highest market share for hospital beds worldwide is held by Europe. Germany has the most hospital beds among the EU members, along with significant income and expansion. Germany has the most ICU beds, according to the most recent OECD 2020 statistics. Germany had 28,000 intensive care beds when the epidemic began, which is higher than most of its neighbors. As of April 18, 2020, 12,336 ICU beds or 41% of the country's total capacity remained unoccupied during the first SARS-CoV-2 pandemic wave. The German government prioritized primary and secondary prevention in order to deal with this health problem, and as a tertiary preventative step, more beds were added to the ICU's current capacity. As of April 27, 2020, the German government added 7,000 beds. With the increase in operations, particularly cardiac, orthopedic, and trauma surgery, the UK hospital bed market is anticipated to expand.
Segment Covered in the Report
By Type
By Application
By Usage
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Bed Market
5.1. COVID-19 Landscape: Medical Bed Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Bed Market, By Type
8.1. Medical Bed Market, by Type, 2023-2032
8.1.1 Electric Bed
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Semi Electric Bed
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Manual Bed
8.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Medical Bed Market, By Application
9.1. Medical Bed Market, by Application, 2023-2032
9.1.1. Outpatient Clinics
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Medical Nursing Homes
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Medical Laboratory and Research
9.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Medical Bed Market, By Usage
10.1. Medical Bed Market, by Usage, 2023-2032
10.1.1. Acute Care
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Long Term Care
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Psychiatric Care
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Maternity
10.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Medical Bed Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2021-2032)
11.1.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.3. Market Revenue and Forecast, by Usage (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.1.5.3. Market Revenue and Forecast, by Usage (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2021-2032)
11.2.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.3. Market Revenue and Forecast, by Usage (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.5.3. Market Revenue and Forecast, by Usage (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.6.3. Market Revenue and Forecast, by Usage (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.2.7.3. Market Revenue and Forecast, by Usage (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2021-2032)
11.3.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.3. Market Revenue and Forecast, by Usage (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.5.3. Market Revenue and Forecast, by Usage (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.6.3. Market Revenue and Forecast, by Usage (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.3.7.3. Market Revenue and Forecast, by Usage (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.5.3. Market Revenue and Forecast, by Usage (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.6.3. Market Revenue and Forecast, by Usage (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2032)
11.4.7.3. Market Revenue and Forecast, by Usage (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.3. Market Revenue and Forecast, by Usage (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.4.3. Market Revenue and Forecast, by Usage (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2032)
11.5.5.3. Market Revenue and Forecast, by Usage (2021-2032)
Chapter 12. Company Profiles
12.1. Invacare Corporation. (US)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Hill-Rom Services, Inc. (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Stryker Corporation (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medical Depot, Inc. (Canada)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gendron Inc. (US)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Arjo. (Sweden)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. HARD Manufacturing Company, Inc. (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. GF Health Products, Inc. (US)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Transfer Master Products, Inc. (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Umano Medical inc. (Canada)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client